Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2ZZL
|
||||
Drug Name |
CHEMBL1672434
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C12H13Br2N3O2S
|
||||
Canonical SMILES |
C[C@H]1C[C@H](CN1C#N)NS(=O)(=O)c2cc(Br)ccc2Br
|
||||
InChI |
InChI=1S/C12H13Br2N3O2S/c1-8-4-10(6-17(8)7-15)16-20(18,19)12-5-9(13)2-3-11(12)14/h2-3,5,8,10,16H,4,6H2,1H3/t8-,10+/m0/s1
|
||||
InChIKey |
XOGLUHPWGGYHRM-WCBMZHEXSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.